\-\ Texto\\:\\ \ \(0\)\
\-\ area\\ of\\ thickening\\ and\\ nodularity\\ in\\ right\\ breast\\ in\\ the\\ upper\\-outer\\ aspect\\.\\ this\\ area\\ is\\ ill\\-defined\\ but\\ not\\ hardened\\.\\ there\\ were\\ no\\ skin\\ changes\\ or\\ redness\\.\ \(0\)\
\-\ ultrasound\\-guided\\ core\\ biopsies\\ were\\ performed\\ for\\ pathologic\\ diagnosis\\ of\\ this\\ lesion\\.\\ final\\ diagnosis\\ on\\ pathology\\:\\ invasive\\ mammary\\ carcinoma\\ with\\ ductal\\ and\\ lobular\\ features\\,\\ nottingham\\ grade\\ ii\\,\\ nottingham\\ score\\ 6\\ \\(tubules\\=3\\,\\ nuclei\\=2\\,\\ mitoses\\=1\\)\\,\\ involving\\ 4\\/4\\ needle\\ core\\ biopsies\\,\\ with\\ greatest\\ tumor\\ size\\ 1\\.1cm\\,\\ no\\ definite\\ venous\\ or\\ lymphatic\\ invasion\\,\\ and\\ no\\ microcalcifications\\ identified\\.\\ er\\+\\/pr\\+\\;\\ her2\\/neu\\ \\-\\.\ \(0\)\
\-\ screening\\ mammogram\\ \\(cc\\ and\\ mlo\\ views\\)\\ of\\ both\\ breasts\\ were\\ performed\\.\\ mmg\\ demonstrated\\ no\\ mass\\ or\\ suspicious\\ microcalcifications\\.\\ however\\,\\ there\\ was\\ a\\ generalized\\,\\ ill\\-defined\\,\\ increased\\ density\\ measuring\\ 2\\.5\\ cm\\ in\\ the\\ 12\\ o\\â\\€\\™clock\\ position\\ of\\ the\\ mid\\ right\\ breast\\ compared\\ to\\ previous\\ mmgs\\,\\ markedly\\ asymmetrical\\ compared\\ to\\ the\\ unremarkable\\ left\\ side\\.\\ there\\ was\\ also\\ mild\\ tissue\\ retraction\\ throughout\\ the\\ dense\\ area\\.\ \(0\)\
\-\ these\\ findings\\ in\\ the\\ r\\ breast\\ on\\ mmg\\ and\\ us\\ when\\ correlated\\ with\\ physical\\ exam\\ were\\ graded\\ bi\\-rads\\ category\\ 4\\ with\\ prompt\\ clinical\\ attention\\ advised\\.\ \(0\)\
\-\ follow\\-up\\ ultrasound\\ examination\\ \\ in\\ the\\ transverse\\ and\\ longitudinal\\ planes\\ of\\ the\\ right\\ breast\\ at\\ 12\\ o\\â\\€\\™clock\\,\\ zone\\ 2\\-c\\,\\ revealed\\ a\\ 1\\.4\\ x\\ 1\\.5\\ cm\\ area\\ of\\ hypoechogenicity\\ suspicious\\ for\\ malignancy\\.\ \(0\)\
\-\ invasive\\ lobular\\ carcinoma\ \(2\)\
\-\ \\>\\>\\ lcis\ \(0\)\
\-\ \\>\\>\\ invasive\\ lobular\\ carcinoma\ \(0\)\
\-\ \\>\\>\\ inflammatory\\ breast\\ cancer\ \(0\)\
\-\ \\<p\\>pt\\ presented\\ to\\ pcp\\ with\\ an\\ area\\ of\\ thickening\\ in\\ the\\ skin\\ and\\ subcutaneous\\ tissues\\ of\\ the\\ upper\\-outer\\ aspect\\ of\\ the\\ r\\ breast\\ at\\ the\\ 10\\ o\\â\\€\\™clock\\ position\\,\\ circular\\ in\\ shape\\ and\\ measuring\\ approximately\\ 5\\ x\\ 5\\ cm\\ which\\ was\\ noticed\\ for\\ several\\ wks\\.\\ no\\ c\\/o\\ pain\\,\\ redness\\,\\ discharge\\,\\ nausea\\,\\ vomiting\\,\\ diarrhea\\,\\ constipation\\,\\ or\\ recent\\ weight\\ change\\.\\ pt\\ has\\ previously\\ had\\ regular\\ annual\\ mammograms\\,\\ the\\ last\\ being\\ one\\ year\\ prior\\ to\\ presentation\\.\\<\\/p\\>\ \(0\)\
\-\ \\<p\\>her\\ relevant\\ history\\ is\\ as\\ follows\\:\ \(0\)\
\-\ age\\ of\\ menarche\\ unknown\\;\\ lmp\\ 33\\ years\\ ago\\;\ \(0\)\
\-\ no\\ fhx\\ or\\ first\\ degree\\ relative\\ with\\ breast\\ or\\ ovarian\\ cancer\\;\ \(0\)\
\-\ no\\ prior\\ personal\\ h\\/o\\ breast\\ disease\\;\ \(0\)\
\-\ taking\\ premarin\\ for\\ \\"many\\"\\ years\\ following\\ tah\\/bso\\;\ \(0\)\
\-\ age\\ at\\ first\\ pregnancy\\ \\=\\ 29\\,\\ did\\ not\\ breast\\ feed\\;\ \(0\)\
\-\ no\\ montly\\ breast\\ self\\ exams\\ performed\\;\ \(0\)\
\-\ active\\ 1ppd\\ smoker\\;\ \(0\)\
\-\ does\\ not\\ exercise\\<\\/p\\>\ \(0\)\
\-\ invasive\\ lobular\\ carcinoma\\ \\(ilc\\)\\ of\\ the\\ breast\\ is\\ the\\ second\\ most\\ common\\ type\\ of\\ primary\\ breast\\ cancer\\,\\ accounting\\ for\\ 10\\-15\\%\\ of\\ cases\\.\\ 6\\-28\\%\\ of\\ cases\\ are\\ bilateral\\,\\ approximately\\ twice\\ the\\ risk\\ of\\ invasive\\ ductal\\ carcinoma\\.\\ \ \(0\)\
\-\ risk\\ factors\\ for\\ breast\\ cancer\\ include\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ age\\ \\>\\ 50\\ \ \(0\)\
\-\ \\â\\€\\¢\\ genetics\\ \\(brca1\\,\\ brca2\\,\\ her2\\,\\ p53\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ personal\\ history\\ of\\ breast\\ cancer\\ \ \(0\)\
\-\ \\â\\€\\¢\\ family\\ history\\,\\ especially\\ in\\ first\\-degree\\ relative\\ \ \(0\)\
\-\ \\â\\€\\¢\\ previous\\ breast\\ biopsy\\ showing\\ benign\\ conditions\\ \\(e\\.g\\.\\ lcis\\ or\\ atypical\\ hyperplasia\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ menarche\\ before\\ age\\ 12\\ or\\ menopause\\ after\\ age\\ 55\\ \ \(0\)\
\-\ \\â\\€\\¢\\ delayed\\ childbirth\\ after\\ age\\ 30\\ \ \(0\)\
\-\ \\â\\€\\¢\\ alcohol\\ \ \(0\)\
\-\ \\â\\€\\¢\\ high\\-fat\\ diet\\ \ \(0\)\
\-\ \\â\\€\\¢\\ obesity\\ \\(weight\\ gained\\ as\\ adult\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ previous\\ radiation\\ therapy\\,\\ e\\.g\\.\\ tx\\ hodgkins\\â\\€\\™\\ disease\\ \ \(0\)\
\-\ \\â\\€\\¢\\ combined\\ estrogen\\ and\\ progesterone\\ replacement\\ therapy\\ \\(chrt\\)\\ \ \(0\)\
\-\ ilc\\ has\\ been\\ historically\\ difficult\\ to\\ diagnose\\ early\\ due\\ to\\ lack\\ of\\ pathomnemonic\\ radiographic\\ signs\\.\\ classically\\,\\ ilc\\ exhibits\\ the\\ \\â\\€\\˜indian\\ file\\â\\€\\™\\ appearance\\ of\\ small\\,\\ regular\\ non\\-cohesive\\ cells\\ arranged\\ in\\ single\\ files\\.\\ the\\ subtle\\ mammographic\\ findings\\ are\\ often\\ due\\ to\\ malignant\\ cells\\ permeating\\ the\\ parenchyma\\ around\\ normal\\ ducts\\,\\ inducing\\ little\\ connective\\ tissue\\ reaction\\.\\ \ \(0\)\
\-\ physical\\ exam\\ may\\ also\\ be\\ non\\-specific\\ in\\ ilc\\ and\\ may\\ include\\ vague\\ areas\\ of\\ thickening\\ which\\ may\\ be\\ confused\\ with\\ benign\\ breast\\ change\\,\\ especially\\ in\\ the\\ younger\\ patient\\.\\ \ \(0\)\
\-\ us\\ and\\ mr\\ imaging\\ has\\ been\\ shown\\ to\\ be\\ more\\ sensitive\\ than\\ mammography\\ for\\ invasive\\ cancer\\,\\ but\\ with\\ the\\ risk\\ of\\ overestimating\\ the\\ extent\\ of\\ the\\ tumor\\.\\ combined\\ mammography\\,\\ clinical\\ exam\\,\\ and\\ mri\\ were\\ more\\ sensitive\\ at\\ detecting\\ ilc\\ than\\ any\\ other\\ individual\\ test\\ or\\ combination\\ of\\ tests\\.\\ \ \(0\)\
\-\ the\\ majority\\ of\\ ilcs\\ are\\ of\\ intermediate\\ histological\\ grade\\ \\(grade\\ 2\\)\\ and\\ er\\+\\;\\ prognosis\\ is\\ similar\\ to\\ that\\ of\\ invasive\\ ductal\\ carcinomas\\ of\\ similar\\ grade\\.\\ \ \(0\)\
\-\ imaging\\ features\\ of\\ primary\\ invasive\\ lobular\\ carcinoma\\ \ \(0\)\
\-\ mammogram\\:\\ \ \(1\)\
\-\ \\â\\€\\¢\\ micro\\-calcification\\ less\\ frequently\\ observed\\ \\(6\\.5\\-25\\%\\)\\ unlike\\ in\\ ductal\\ ca\\ \ \(1\)\
\-\ \\â\\€\\¢\\ speculated\\ mass\\ \ \(1\)\
\-\ \\â\\€\\¢\\ asymmetric\\ density\\ without\\ definable\\ margins\\ \ \(1\)\
\-\ \\â\\€\\¢\\ architectural\\ distortion\\ without\\ an\\ obvious\\ mass\\ \ \(1\)\
\-\ \\â\\€\\¢\\ better\\ demonstrated\\ on\\ craniocaudal\\ view\\ \ \(1\)\
\-\ because\\ these\\ subtle\\ findings\\ are\\ often\\ confused\\ with\\ normal\\ glandular\\ tissue\\,\\ the\\ relative\\ infrequency\\ of\\ micro\\-calicification\\,\\ and\\ the\\ insidious\\ growth\\ of\\ the\\ tumor\\,\\ ilc\\ is\\ often\\ undetected\\ until\\ clinically\\ palpable\\.\\ at\\ this\\ stage\\,\\ skin\\ tethering\\,\\ skin\\ thickening\\,\\ and\\ nipple\\ retraction\\ are\\ often\\ apparent\\.\\ \ \(0\)\
\-\ ultrasound\\:\\ \ \(11\)\
\-\ \\â\\€\\¢\\ useful\\ adjunct\\ to\\ mammography\\ \ \(1\)\
\-\ \\â\\€\\¢\\ ill\\-definied\\ hypoechoic\\ mass\\ with\\ acoustic\\ attenuation\\ \ \(1\)\
\-\ \\â\\€\\¢\\ fna\\ often\\ do\\ not\\ yield\\ much\\ information\\ due\\ to\\ the\\ relative\\ sparseness\\ of\\ malignancy\\ cells\\ within\\ these\\ tumors\\ \ \(0\)\
\-\ \\â\\€\\¢\\ wide\\-bore\\ needle\\ biopsy\\ should\\ be\\ performed\\ if\\ fnas\\ inconclusive\\ \ \(0\)\
\-\ contrast\\-enhanced\\ mri\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ highly\\ sensitive\\ in\\ detecting\\ ilc\\ and\\ the\\ extent\\ of\\ ilc\\ \ \(0\)\
\-\ \\â\\€\\¢\\ may\\ be\\ of\\ value\\ in\\ preoperative\\ planning\\ as\\ well\\ as\\ the\\ diagnosis\\ of\\ multifocal\\ or\\ contralateral\\ involvement\\ \ \(1\)\
\-\ american\\ college\\ of\\ radiology\\ \\(acr\\)\\ \\/\\ breast\\ imaging\\ reporting\\ and\\ data\\ system\\ \\(bi\\-rads\\)\\ \ \(0\)\
\-\ bi\\-rads\\ assessment\\ categories\\:\\ \ \(0\)\
\-\ category\\ 0\\:\\ need\\ additional\\ imaging\\ evaluation\\ \ \(0\)\
\-\ category\\ 1\\:\\ negative\\ \ \(0\)\
\-\ category\\ 2\\:\\ benign\\ finding\\ \ \(0\)\
\-\ category\\ 3\\:\\ probably\\ benign\\ finding\\ \\-\\ short\\ interval\\ follow\\-up\\ suggested\\ \ \(0\)\
\-\ category\\ 4\\:\\ suspicious\\ abnormality\\ \\-\\ biopsy\\ should\\ be\\ considered\\ \ \(0\)\
\-\ category\\ 5\\:\\ highly\\ suggestive\\ of\\ malignancy\\ \\-\\ appropriate\\ action\\ should\\ be\\ taken\\ \ \(0\)\
\-\ metastatic\\ manifestations\\ of\\ invasive\\ lobular\\ breast\\ carcinoma\\ \ \(0\)\
\-\ gastrointestinal\\,\\ gynecological\\,\\ peritoneal\\,\\ retroperitoneal\\,\\ bone\\ marrow\\,\\ and\\ leoptomeningeal\\ metastases\\ are\\ more\\ frequently\\ seen\\ with\\ ilc\\ than\\ with\\ idc\\.\\ ct\\,\\ mri\\,\\ and\\ pet\\ scans\\ are\\ useful\\,\\ but\\ somewhat\\ limited\\ in\\ revealing\\ the\\ full\\ extent\\ of\\ metastatic\\ ilc\\.\\ knowledge\\ of\\ pattern\\ of\\ metastasis\\ is\\ useful\\ for\\ interpretation\\ of\\ these\\ imaging\\ studies\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ bone\\ \\(most\\ frequent\\ metastasis\\ site\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ gastrointestinal\\ \\â\\€\\“\\ \ \(0\)\
\-\ \\ \\ o\\ esophagus\\,\\ stomach\\ \\(produces\\ linitis\\ plastica\\)\\,\\ small\\ bowel\\ \\(50\\%\\ of\\ mets\\)\\ and\\ large\\ bowel\\ wall\\ thickening\\ \ \(0\)\
\-\ \\ \\ o\\ can\\ present\\ as\\ obstruction\\,\\ hemorrhage\\,\\ or\\ performation\\ \ \(0\)\
\-\ \\â\\€\\¢\\ gynecologic\\ \\â\\€\\“\\ \ \(0\)\
\-\ \\ \\ o\\ uterus\\ \\â\\€\\“\\ ilc\\ is\\ most\\ common\\ extragenital\\ neoplasm\\ to\\ metastasize\\ to\\ uterus\\ \ \(0\)\
\-\ \\ \\ o\\ ovary\\,\\ vagina\\,\\ parametrium\\ \ \(0\)\
\-\ \\â\\€\\¢\\ genitourinary\\ system\\ \\â\\€\\“\\ direct\\ invation\\ of\\ kidneys\\ and\\ ureters\\ \ \(0\)\
\-\ \\â\\€\\¢\\ peritoneum\\ \\â\\€\\“\\ manifests\\ as\\ small\\ nodules\\ which\\ may\\ become\\ confluent\\ \ \(0\)\
\-\ \\â\\€\\¢\\ retroperitoneum\\ \\â\\€\\“\\ ureteric\\ obstruction\\ and\\ hydronephrosis\\ \ \(0\)\
\-\ \\â\\€\\¢\\ leptomeninges\\ \ \(0\)\
\-\ \\â\\€\\¢\\ orbital\\ metastases\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ilc\\:\\ 0\\.08498746946856396\ \(0\)\
\-\ breast\\:\\ 0\\.04973360472300608\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.04257444776465603\ \(0\)\
\-\ category\\:\\ 0\\.03433523066931471\ \(0\)\
\-\ invasive\\:\\ 0\\.033868158301715266\ \(0\)\
\-\ o\\:\\ 0\\.031930064486639716\ \(0\)\
\-\ \\>\\:\\ 0\\.027371465960871345\ \(0\)\
\-\ lobular\\:\\ 0\\.025380548873280756\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.020222813975760725\ \(0\)\
\-\ bi\\-rads\\:\\ 0\\.01894674981121577\ \(0\)\
\-\ clock\\:\\ 0\\.018467376743396432\ \(0\)\
\-\ \\;\\:\\ 0\\.017751281230960505\ \(0\)\
\-\ nottingham\\:\\ 0\\.01545226717610254\ \(0\)\
\-\ mmg\\:\\ 0\\.01545226717610254\ \(0\)\
\-\ \\/p\\:\\ 0\\.01545226717610254\ \(0\)\
\-\ carcinoma\\:\\ 0\\.014858451963287524\ \(0\)\
\-\ cancer\\:\\ 0\\.014772122336712176\ \(0\)\
\-\ relative\\:\\ 0\\.01427024117652322\ \(0\)\
\-\ upper\\-outer\\:\\ 0\\.014237285264516307\ \(0\)\
\-\ lcis\\:\\ 0\\.014237285264516307\ \(0\)\
\-\ ductal\\:\\ 0\\.014121040074266266\ \(0\)\
\-\ \\,\\:\\ 0\\.013760897283087352\ \(0\)\
\-\ age\\:\\ 0\\.013677004341161998\ \(0\)\
\-\ mammography\\:\\ 0\\.013055313292523506\ \(0\)\
\-\ menarche\\:\\ 0\\.013022303352930075\ \(0\)\
\-\ \\:\\:\\ 0\\.012877802460892766\ \(0\)\
\-\ thickening\\:\\ 0\\.012693359201110218\ \(0\)\
\-\ sensitive\\:\\ 0\\.012202798827530746\ \(0\)\
\-\ often\\:\\ 0\\.011947736847150099\ \(0\)\
\-\ area\\:\\ 0\\.011839773199536666\ \(0\)\
\-\ useful\\:\\ 0\\.011723425759711411\ \(0\)\
\-\ \\<\\:\\ 0\\.011562017624896724\ \(0\)\
\-\ skin\\:\\ 0\\.011506148765079677\ \(0\)\
\-\ grade\\:\\ 0\\.011410470790362736\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.011192054073818826\ \(0\)\
\-\ extent\\:\\ 0\\.011150238682199252\ \(0\)\
\-\ personal\\:\\ 0\\.01109660258401139\ \(0\)\
\-\ suspicious\\:\\ 0\\.010819556682315727\ \(0\)\
\-\ benign\\:\\ 0\\.010338476308617709\ \(0\)\
\-\ microcalcifications\\:\\ 0\\.01003413842350251\ \(0\)\
\-\ redness\\:\\ 0\\.009956221223553635\ \(0\)\
\-\ detecting\\:\\ 0\\.009881620672425158\ \(0\)\
\-\ biopsies\\:\\ 0\\.009675164869346484\ \(0\)\
\-\ or\\:\\ 0\\.009655346396670273\ \(0\)\
\-\ retraction\\:\\ 0\\.009490483860305597\ \(0\)\
\-\ 12\\:\\ 0\\.009195613751417043\ \(0\)\
\-\ cells\\:\\ 0\\.009009062298378608\ \(0\)\
\-\ \\(\\:\\ 0\\.008863334064341847\ \(0\)\
\-\ confused\\:\\ 0\\.008859453651661587\ \(0\)\
\-\ imaging\\:\\ 0\\.008773329642662588\ \(0\)\
\-\ \\)\\:\\ 0\\.008755063706911719\ \(0\)\
\-\ previous\\:\\ 0\\.00872484714813312\ \(0\)\
\-\ malignancy\\:\\ 0\\.00868209380666481\ \(0\)\
\-\ were\\:\\ 0\\.008502569398290628\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.008460182957760251\ \(0\)\
\-\ performed\\:\\ 0\\.008352597129631267\ \(0\)\
\-\ core\\:\\ 0\\.008304962278809428\ \(0\)\
\-\ combined\\:\\ 0\\.008275501948719366\ \(0\)\
\-\ may\\:\\ 0\\.008213533606039105\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.008162375706585146\ \(0\)\
\-\ risk\\:\\ 0\\.008138141929953777\ \(0\)\
\-\ be\\:\\ 0\\.008084397075729628\ \(0\)\
\-\ biopsy\\:\\ 0\\.00797114787459271\ \(0\)\
\-\ e\\.g\\:\\ 0\\.007931742301171092\ \(0\)\
\-\ mammogram\\:\\ 0\\.007815617173140941\ \(0\)\
\-\ these\\:\\ 0\\.00779612512518086\ \(0\)\
\-\ tubules\\=3\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ nuclei\\=2\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ mitoses\\=1\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ er\\+\\/pr\\+\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ her2\\/neu\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ mmgs\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ 2\\-c\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ tah\\/bso\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ 6\\-28\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ brca1\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ brca2\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ high\\-fat\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ chrt\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ non\\-cohesive\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ permeating\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ overestimating\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ ilcs\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ micro\\-calcification\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ 6\\.5\\-25\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ definable\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ infrequency\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ micro\\-calicification\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ sparseness\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ wide\\-bore\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ gynecological\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ leoptomeningeal\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ performation\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ extragenital\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ parametrium\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ invation\\:\\ 0\\.00772613358805127\ \(0\)\
\-\ p\\:\\ 0\\.007685717134308824\ \(0\)\
\-\ needle\\:\\ 0\\.007624207371274171\ \(0\)\
\-\ highly\\:\\ 0\\.007213037788210485\ \(0\)\
\-\ should\\:\\ 0\\.007162686788489396\ \(0\)\
\-\ are\\:\\ 0\\.0071464654756417285\ \(0\)\
\-\ presentation\\.\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ premarin\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ her2\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ first\\-degree\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ menopause\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ pathomnemonic\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ files\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ inducing\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ er\\+\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ ill\\-definied\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ fnas\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ idc\\:\\ 0\\.0071186426322581535\ \(0\)\
\-\ uterus\\:\\ 0\\.007060520037133133\ \(0\)\
\-\ \\%\\:\\ 0\\.006987979082720448\ \(0\)\
\-\ regular\\:\\ 0\\.006906785452699994\ \(0\)\
\-\ subtle\\:\\ 0\\.006880226635836538\ \(0\)\
\-\ r\\:\\ 0\\.006802882543095191\ \(0\)\
\-\ as\\:\\ 0\\.006797077156323196\ \(0\)\
\-\ hardened\\:\\ 0\\.0067632832035919264\ \(0\)\
\-\ 1\\.1cm\\:\\ 0\\.0067632832035919264\ \(0\)\
\-\ montly\\:\\ 0\\.0067632832035919264\ \(0\)\
\-\ 1ppd\\:\\ 0\\.0067632832035919264\ \(0\)\
\-\ linitis\\:\\ 0\\.0067632832035919264\ \(0\)\
\-\ plastica\\:\\ 0\\.0067632832035919264\ \(0\)\
\-\ 5\\:\\ 0\\.0065736032141389044\ \(0\)\
\-\ hypoechogenicity\\:\\ 0\\.006511151676465037\ \(0\)\
\-\ p53\\:\\ 0\\.006511151676465037\ \(0\)\
\-\ ureteric\\:\\ 0\\.006511151676465037\ \(0\)\
\-\ frequently\\:\\ 0\\.006491727669780815\ \(0\)\
\-\ \\-\\:\\ 0\\.0064214845178207315\ \(0\)\
\-\ metastases\\:\\ 0\\.006399180455815923\ \(0\)\
\-\ compared\\:\\ 0\\.006340090083612047\ \(0\)\
\-\ features\\:\\ 0\\.006320827819675859\ \(0\)\
\-\ childbirth\\:\\ 0\\.006315583270405257\ \(0\)\
\-\ us\\:\\ 0\\.006282926918688715\ \(0\)\
\-\ position\\:\\ 0\\.006236674937666463\ \(0\)\
\-\ especially\\:\\ 0\\.006165120170759792\ \(0\)\
\-\ 4\\/4\\:\\ 0\\.006155792247798811\ \(0\)\
\-\ historically\\:\\ 0\\.006155792247798811\ \(0\)\
\-\ speculated\\:\\ 0\\.006155792247798811\ \(0\)\
\-\ no\\:\\ 0\\.00603291253780054\ \(0\)\
\-\ cm\\:\\ 0\\.006026177347459209\ \(0\)\
\-\ gained\\:\\ 0\\.006020690863199987\ \(0\)\
\-\ undetected\\:\\ 0\\.006020690863199987\ \(0\)\
\-\ acr\\:\\ 0\\.006020690863199987\ \(0\)\
\-\ gynecologic\\:\\ 0\\.006020690863199987\ \(0\)\
\-\ due\\:\\ 0\\.005995470165520174\ \(0\)\
\-\ measuring\\:\\ 0\\.005990106437245829\ \(0\)\
\-\ fhx\\:\\ 0\\.005903660720671921\ \(0\)\
\-\ progesterone\\:\\ 0\\.005903660720671921\ \(0\)\
\-\ leptomeninges\\:\\ 0\\.005903660720671921\ \(0\)\
\-\ system\\:\\ 0\\.005897423261000522\ \(0\)\
\-\ than\\:\\ 0\\.005887069732475742\ \(0\)\
\-\ similar\\:\\ 0\\.005874998455636965\ \(0\)\
\-\ change\\:\\ 0\\.00583824976419955\ \(0\)\
\-\ lmp\\:\\ 0\\.005800432819132584\ \(0\)\
\-\ indian\\:\\ 0\\.005800432819132584\ \(0\)\
\-\ reporting\\:\\ 0\\.005800432819132584\ \(0\)\
\-\ asymmetrical\\:\\ 0\\.005708092314612141\ \(0\)\
\-\ hodgkins\\:\\ 0\\.005708092314612141\ \(0\)\
\-\ \\â\\€\\˜\\:\\ 0\\.005708092314612141\ \(0\)\
\-\ file\\:\\ 0\\.005708092314612141\ \(0\)\
\-\ tethering\\:\\ 0\\.005708092314612141\ \(0\)\
\-\ 50\\:\\ 0\\.005698506602355486\ \(0\)\
\-\ ultrasound\\-guided\\:\\ 0\\.005624560167544371\ \(0\)\
\-\ glandular\\:\\ 0\\.005624560167544371\ \(0\)\
\-\ yield\\:\\ 0\\.005624560167544371\ \(0\)\
\-\ action\\:\\ 0\\.005624560167544371\ \(0\)\
\-\ more\\:\\ 0\\.005619219042889131\ \(0\)\
\-\ metastasis\\:\\ 0\\.005606919064504692\ \(0\)\
\-\ pt\\:\\ 0\\.0055690863359031595\ \(0\)\
\-\ circular\\:\\ 0\\.005548301292005695\ \(0\)\
\-\ relevant\\:\\ 0\\.005548301292005695\ \(0\)\
\-\ estrogen\\:\\ 0\\.005548301292005695\ \(0\)\
\-\ inconclusive\\:\\ 0\\.005548301292005695\ \(0\)\
\-\ in\\:\\ 0\\.005539840887032273\ \(0\)\
\-\ feed\\:\\ 0\\.005478149926822928\ \(0\)\
\-\ adjunct\\:\\ 0\\.005478149926822928\ \(0\)\
\-\ vagina\\:\\ 0\\.005478149926822928\ \(0\)\
\-\ retroperitoneum\\:\\ 0\\.005478149926822928\ \(0\)\
\-\ mammographic\\:\\ 0\\.005413199907406871\ \(0\)\
\-\ college\\:\\ 0\\.005413199907406871\ \(0\)\
\-\ knowledge\\:\\ 0\\.005413199907406871\ \(0\)\
\-\ manifests\\:\\ 0\\.005413199907406871\ \(0\)\
\-\ weight\\:\\ 0\\.005368879553270579\ \(0\)\
\-\ wks\\:\\ 0\\.005352732885945914\ \(0\)\
\-\ genetics\\:\\ 0\\.005352732885945914\ \(0\)\
\-\ interpretation\\:\\ 0\\.005352732885945914\ \(0\)\
\-\ tissue\\:\\ 0\\.005325384369288152\ \(0\)\
\-\ mammary\\:\\ 0\\.005296169764878805\ \(0\)\
\-\ arranged\\:\\ 0\\.005296169764878805\ \(0\)\
\-\ metastasize\\:\\ 0\\.005296169764878805\ \(0\)\
\-\ obstruction\\:\\ 0\\.005282033389289107\ \(0\)\
\-\ tumor\\:\\ 0\\.005238121739555157\ \(0\)\
\-\ correlated\\:\\ 0\\.005192941863339469\ \(0\)\
\-\ most\\:\\ 0\\.005187121319179867\ \(0\)\
\-\ small\\:\\ 0\\.005175920993114247\ \(0\)\
\-\ mri\\:\\ 0\\.00516198734859234\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005159209458668939\ \(0\)\
\-\ insidious\\:\\ 0\\.005145556042769552\ \(0\)\
\-\ for\\:\\ 0\\.005112064144734199\ \(0\)\
\-\ accounting\\:\\ 0\\.005100601358819025\ \(0\)\
\-\ 10\\-15\\:\\ 0\\.005100601358819025\ \(0\)\
\-\ categories\\:\\ 0\\.005100601358819025\ \(0\)\
\-\ peritoneum\\:\\ 0\\.005100601358819025\ \(0\)\
\-\ at\\:\\ 0\\.005073458163153519\ \(0\)\
\-\ fna\\:\\ 0\\.005057840478740644\ \(0\)\
\-\ first\\:\\ 0\\.005026263689370468\ \(0\)\
\-\ self\\:\\ 0\\.005017069211751255\ \(0\)\
\-\ exhibits\\:\\ 0\\.005017069211751255\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.005017069211751255\ \(0\)\
\-\ genitourinary\\:\\ 0\\.005017069211751255\ \(0\)\
\-\ cases\\:\\ 0\\.004990027807153606\ \(0\)\
\-\ lymphatic\\:\\ 0\\.004978110611776818\ \(0\)\
\-\ architectural\\:\\ 0\\.004978110611776818\ \(0\)\
\-\ x\\:\\ 0\\.00494139585512266\ \(0\)\
\-\ confluent\\:\\ 0\\.004940810336212579\ \(0\)\
\-\ exam\\:\\ 0\\.004935759701883098\ \(0\)\
\-\ density\\:\\ 0\\.004928363465135774\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.004872983332939075\ \(0\)\
\-\ to\\:\\ 0\\.004865806669376705\ \(0\)\
\-\ score\\:\\ 0\\.004837582434673242\ \(0\)\
\-\ planning\\:\\ 0\\.004837582434673242\ \(0\)\
\-\ revealing\\:\\ 0\\.004837582434673242\ \(0\)\
\-\ finding\\:\\ 0\\.004827452243713377\ \(0\)\
\-\ graded\\:\\ 0\\.0048057089516137545\ \(0\)\
\-\ carcinomas\\:\\ 0\\.0048057089516137545\ \(0\)\
\-\ but\\:\\ 0\\.004791857934356366\ \(0\)\
\-\ findings\\:\\ 0\\.00478221806079744\ \(0\)\
\-\ 1\\.4\\:\\ 0\\.0047749540700964275\ \(0\)\
\-\ twice\\:\\ 0\\.0047749540700964275\ \(0\)\
\-\ individual\\:\\ 0\\.0047749540700964275\ \(0\)\
\-\ pcp\\:\\ 0\\.004745241930152798\ \(0\)\
\-\ mammograms\\:\\ 0\\.004745241930152798\ \(0\)\
\-\ diagnose\\:\\ 0\\.004745241930152798\ \(0\)\
\-\ nodularity\\:\\ 0\\.004716504136267618\ \(0\)\
\-\ mlo\\:\\ 0\\.004716504136267618\ \(0\)\
\-\ advised\\:\\ 0\\.004716504136267618\ \(0\)\
\-\ unlike\\:\\ 0\\.004716504136267618\ \(0\)\
\-\ aspect\\:\\ 0\\.004705156765089145\ \(0\)\
\-\ bowel\\:\\ 0\\.004697552204881261\ \(0\)\
\-\ obesity\\:\\ 0\\.004688678809085689\ \(0\)\
\-\ histological\\:\\ 0\\.004661709783085029\ \(0\)\
\-\ breasts\\:\\ 0\\.0046355459240581395\ \(0\)\
\-\ tx\\:\\ 0\\.0046355459240581395\ \(0\)\
\-\ produces\\:\\ 0\\.0046355459240581395\ \(0\)\
\-\ approximately\\:\\ 0\\.004634211790632048\ \(0\)\
\-\ prompt\\:\\ 0\\.004610140545553974\ \(0\)\
\-\ attention\\:\\ 0\\.004610140545553974\ \(0\)\
\-\ constipation\\:\\ 0\\.004610140545553974\ \(0\)\
\-\ ureters\\:\\ 0\\.004610140545553974\ \(0\)\
\-\ clinical\\:\\ 0\\.004608781419922882\ \(0\)\
\-\ diet\\:\\ 0\\.004585450907546353\ \(0\)\
\-\ preoperative\\:\\ 0\\.004585450907546353\ \(0\)\
\-\ 0\\:\\ 0\\.0044931104030259085\ \(0\)\
\-\ smoker\\:\\ 0\\.004450349522947528\ \(0\)\
\-\ distortion\\:\\ 0\\.004450349522947528\ \(0\)\
\-\ nipple\\:\\ 0\\.004450349522947528\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0044436855127192\ \(0\)\
\-\ primary\\:\\ 0\\.004437132800868881\ \(0\)\
\-\ connective\\:\\ 0\\.004409578255958139\ \(0\)\
\-\ years\\:\\ 0\\.00439832276427429\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004395127050757173\ \(0\)\
\-\ c\\/o\\:\\ 0\\.004389882501486572\ \(0\)\
\-\ classically\\:\\ 0\\.0043706196559837015\ \(0\)\
\-\ younger\\:\\ 0\\.0043706196559837015\ \(0\)\
\-\ non\\-specific\\:\\ 0\\.004333319380419464\ \(0\)\
\-\ not\\:\\ 0\\.004328899813293376\ \(0\)\
\-\ intermediate\\:\\ 0\\.004315248138348704\ \(0\)\
\-\ mets\\:\\ 0\\.004315248138348704\ \(0\)\
\-\ planes\\:\\ 0\\.004297541996966128\ \(0\)\
\-\ ducts\\:\\ 0\\.004297541996966128\ \(0\)\
\-\ of\\:\\ 0\\.00428848346495663\ \(0\)\
\-\ manifestations\\:\\ 0\\.004263168015236696\ \(0\)\
\-\ value\\:\\ 0\\.004246473716401733\ \(0\)\
\-\ exams\\:\\ 0\\.004230091478880126\ \(0\)\
\-\ has\\:\\ 0\\.004219193612167251\ \(0\)\
\-\ include\\:\\ 0\\.004201846604785779\ \(0\)\
\-\ acoustic\\:\\ 0\\.004198217995820638\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.004198217995820638\ \(0\)\
\-\ which\\:\\ 0\\.00419406990510749\ \(0\)\
\-\ 4\\:\\ 0\\.004173482743521552\ \(0\)\
\-\ mass\\:\\ 0\\.004166383898150971\ \(0\)\
\-\ greatest\\:\\ 0\\.004137750974359683\ \(0\)\
\-\ contralateral\\:\\ 0\\.004137750974359683\ \(0\)\
\-\ noticed\\:\\ 0\\.004094990094281302\ \(0\)\
\-\ information\\:\\ 0\\.004081187853292573\ \(0\)\
\-\ been\\:\\ 0\\.0040750129526099755\ \(0\)\
\-\ little\\:\\ 0\\.004067599609176915\ \(0\)\
\-\ definite\\:\\ 0\\.004054218827291913\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.004054218827291913\ \(0\)\
\-\ data\\:\\ 0\\.004054218827291913\ \(0\)\
\-\ final\\:\\ 0\\.004041039267813788\ \(0\)\
\-\ ovary\\:\\ 0\\.004041039267813788\ \(0\)\
\-\ follows\\:\\ 0\\.004028054968265023\ \(0\)\
\-\ vague\\:\\ 0\\.004028054968265023\ \(0\)\
\-\ multifocal\\:\\ 0\\.004028054968265023\ \(0\)\
\-\ assessment\\:\\ 0\\.004028054968265023\ \(0\)\
\-\ cc\\:\\ 0\\.004015260227317474\ \(0\)\
\-\ therapy\\:\\ 0\\.004004628915408611\ \(0\)\
\-\ probably\\:\\ 0\\.003990217832537409\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.003990217832537409\ \(0\)\
\-\ zone\\:\\ 0\\.003977959951753237\ \(0\)\
\-\ taking\\:\\ 0\\.003977959951753237\ \(0\)\
\-\ \\=\\:\\ 0\\.0039305741311833195\ \(0\)\
\-\ pet\\:\\ 0\\.0039305741311833195\ \(0\)\
\-\ common\\:\\ 0\\.0039198373566282155\ \(0\)\
\-\ generalized\\:\\ 0\\.0039191174426930885\ \(0\)\
\-\ longitudinal\\:\\ 0\\.0039191174426930885\ \(0\)\
\-\ tests\\:\\ 0\\.0039191174426930885\ \(0\)\
\-\ h\\/o\\:\\ 0\\.003907808586570471\ \(0\)\
\-\ 29\\:\\ 0\\.003907808586570471\ \(0\)\
\-\ subcutaneous\\:\\ 0\\.0038966437962309176\ \(0\)\
\-\ shape\\:\\ 0\\.0038966437962309176\ \(0\)\
\-\ peritoneal\\:\\ 0\\.0038966437962309176\ \(0\)\
\-\ diarrhea\\:\\ 0\\.0038856194472327928\ \(0\)\
\-\ 33\\:\\ 0\\.0038856194472327928\ \(0\)\
\-\ better\\:\\ 0\\.003863978244261389\ \(0\)\
\-\ prior\\:\\ 0\\.0038459470152539237\ \(0\)\
\-\ exercise\\:\\ 0\\.003842858567154412\ \(0\)\
\-\ suggested\\:\\ 0\\.0038121036856370856\ \(0\)\
\-\ obvious\\:\\ 0\\.003782391545693456\ \(0\)\
\-\ alcohol\\:\\ 0\\.0037727072019716466\ \(0\)\
\-\ combination\\:\\ 0\\.0037727072019716466\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.0037727072019716466\ \(0\)\
\-\ metastatic\\:\\ 0\\.003770568630352481\ \(0\)\
\-\ the\\:\\ 0\\.0037561155353307623\ \(0\)\
\-\ annual\\:\\ 0\\.0037536537518082754\ \(0\)\
\-\ adult\\:\\ 0\\.0037536537518082754\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.0037442801417147194\ \(0\)\
\-\ frequent\\:\\ 0\\.0037442801417147194\ \(0\)\
\-\ need\\:\\ 0\\.0037350057251235385\ \(0\)\
\-\ conditions\\:\\ 0\\.003725828424626347\ \(0\)\
\-\ bone\\:\\ 0\\.0037220590384923224\ \(0\)\
\-\ \\/\\:\\ 0\\.003698859398625687\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.003690051041173012\ \(0\)\
\-\ majority\\:\\ 0\\.0036813303305216817\ \(0\)\
\-\ somewhat\\:\\ 0\\.0036813303305216817\ \(0\)\
\-\ physical\\:\\ 0\\.0036748558625438006\ \(0\)\
\-\ interval\\:\\ 0\\.0036726955395987963\ \(0\)\
\-\ replacement\\:\\ 0\\.003655677059443581\ \(0\)\
\-\ asymmetric\\:\\ 0\\.0036389827606086167\ \(0\)\
\-\ discharge\\:\\ 0\\.003630753365034699\ \(0\)\
\-\ 55\\:\\ 0\\.003630753365034699\ \(0\)\
\-\ invasion\\:\\ 0\\.0036065188941052425\ \(0\)\
\-\ observed\\:\\ 0\\.0035907270400275227\ \(0\)\
\-\ american\\:\\ 0\\.003567560294130805\ \(0\)\
\-\ become\\:\\ 0\\.003567560294130805\ \(0\)\
\-\ prognosis\\:\\ 0\\.0035524491579042436\ \(0\)\
\-\ orbital\\:\\ 0\\.0035524491579042436\ \(0\)\
\-\ markedly\\:\\ 0\\.003544990183611598\ \(0\)\
\-\ dense\\:\\ 0\\.0035375941549999727\ \(0\)\
\-\ direct\\:\\ 0\\.0035375941549999727\ \(0\)\
\-\ short\\:\\ 0\\.0035302600185665666\ \(0\)\
\-\ appropriate\\:\\ 0\\.0035302600185665666\ \(0\)\
\-\ without\\:\\ 0\\.003526754016403436\ \(0\)\
\-\ degree\\:\\ 0\\.0035086188155951624\ \(0\)\
\-\ ca\\:\\ 0\\.003487499138488186\ \(0\)\
\-\ scans\\:\\ 0\\.003487499138488186\ \(0\)\
\-\ and\\:\\ 0\\.0034708134321724854\ \(0\)\
\-\ much\\:\\ 0\\.0034668764413714514\ \(0\)\
\-\ is\\:\\ 0\\.003449636677206906\ \(0\)\
\-\ showing\\:\\ 0\\.003446727871498797\ \(0\)\
\-\ kidneys\\:\\ 0\\.003446727871498797\ \(0\)\
\-\ ovarian\\:\\ 0\\.0034270321170272295\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.0034141432937233773\ \(0\)\
\-\ lack\\:\\ 0\\.003407769271524359\ \(0\)\
\-\ reaction\\:\\ 0\\.0034014412715475954\ \(0\)\
\-\ margins\\:\\ 0\\.0034014412715475954\ \(0\)\
\-\ factors\\:\\ 0\\.003364403752450415\ \(0\)\
\-\ there\\:\\ 0\\.0033436868268141686\ \(0\)\
\-\ apparent\\:\\ 0\\.0033116264868999733\ \(0\)\
\-\ stomach\\:\\ 0\\.0033116264868999733\ \(0\)\
\-\ marrow\\:\\ 0\\.0032947174571587995\ \(0\)\
\-\ until\\:\\ 0\\.0032891528404378014\ \(0\)\
\-\ clinically\\:\\ 0\\.00328362333194239\ \(0\)\
\-\ pathologic\\:\\ 0\\.003278128491439677\ \(0\)\
\-\ difficult\\:\\ 0\\.003278128491439677\ \(0\)\
\-\ growth\\:\\ 0\\.0032564872884682733\ \(0\)\
\-\ do\\:\\ 0\\.0032511594654390163\ \(0\)\
\-\ esophagus\\:\\ 0\\.0032511594654390163\ \(0\)\
\-\ atypical\\:\\ 0\\.0032458638348904075\ \(0\)\
\-\ full\\:\\ 0\\.0032353676113612965\ \(0\)\
\-\ ii\\:\\ 0\\.003230166265594588\ \(0\)\
\-\ 2\\:\\ 0\\.0032254241831911417\ \(0\)\
\-\ pregnancy\\:\\ 0\\.0032198552738508662\ \(0\)\
\-\ last\\:\\ 0\\.0031995902279079616\ \(0\)\
\-\ test\\:\\ 0\\.0031995902279079616\ \(0\)\
\-\ suggestive\\:\\ 0\\.0031995902279079616\ \(0\)\
\-\ screening\\:\\ 0\\.003194596344371908\ \(0\)\
\-\ stage\\:\\ 0\\.003194596344371908\ \(0\)\
\-\ parenchyma\\:\\ 0\\.0031896307549453716\ \(0\)\
\-\ before\\:\\ 0\\.0031700450418060233\ \(0\)\
\-\ radiology\\:\\ 0\\.00316521624617853\ \(0\)\
\-\ site\\:\\ 0\\.00316521624617853\ \(0\)\
\-\ limited\\:\\ 0\\.0031604139098379293\ \(0\)\
\-\ previously\\:\\ 0\\.0031461627960151597\ \(0\)\
\-\ mid\\:\\ 0\\.0031321397098219594\ \(0\)\
\-\ taken\\:\\ 0\\.0031229141068535218\ \(0\)\
\-\ around\\:\\ 0\\.0031183374688332315\ \(0\)\
\-\ nodules\\:\\ 0\\.0031047492247175735\ \(0\)\
\-\ history\\:\\ 0\\.0031031057082570117\ \(0\)\
\-\ after\\:\\ 0\\.003099038041383352\ \(0\)\
\-\ views\\:\\ 0\\.003086953198283967\ \(0\)\
\-\ many\\:\\ 0\\.003078188883354446\ \(0\)\
\-\ tissues\\:\\ 0\\.0030738393747285655\ \(0\)\
\-\ family\\:\\ 0\\.0030695113452451454\ \(0\)\
\-\ pathology\\:\\ 0\\.003065204583805681\ \(0\)\
\-\ delayed\\:\\ 0\\.0030481861036504646\ \(0\)\
\-\ single\\:\\ 0\\.003035635662130089\ \(0\)\
\-\ considered\\:\\ 0\\.0030232624092415834\ \(0\)\
\-\ nausea\\:\\ 0\\.003015109567293894\ \(0\)\
\-\ attenuation\\:\\ 0\\.0030110614114163352\ \(0\)\
\-\ transverse\\:\\ 0\\.0030030207661262028\ \(0\)\
\-\ shown\\:\\ 0\\.0030030207661262028\ \(0\)\
\-\ additional\\:\\ 0\\.0030030207661262028\ \(0\)\
\-\ also\\:\\ 0\\.002952882723348206\ \(0\)\
\-\ unknown\\:\\ 0\\.00292276906277345\ \(0\)\
\-\ 30\\:\\ 0\\.0028800081826950703\ \(0\)\
\-\ second\\:\\ 0\\.0028765371912699194\ \(0\)\
\-\ pattern\\:\\ 0\\.002862789078940647\ \(0\)\
\-\ vomiting\\:\\ 0\\.0028593854855783352\ \(0\)\
\-\ active\\:\\ 0\\.0028593854855783352\ \(0\)\
\-\ radiographic\\:\\ 0\\.0028425630077026586\ \(0\)\
\-\ tumors\\:\\ 0\\.0028130730566787916\ \(0\)\
\-\ view\\:\\ 0\\.002809856817512304\ \(0\)\
\-\ throughout\\:\\ 0\\.002803459532252346\ \(0\)\
\-\ studies\\:\\ 0\\.002797108604539141\ \(0\)\
\-\ ago\\:\\ 0\\.0027876676781746264\ \(0\)\
\-\ abnormality\\:\\ 0\\.002762978040167005\ \(0\)\
\-\ involvement\\:\\ 0\\.002744906798096246\ \(0\)\
\-\ early\\:\\ 0\\.002738964916426326\ \(0\)\
\-\ venous\\:\\ 0\\.0027184799460623394\ \(0\)\
\-\ malignant\\:\\ 0\\.0027069856935839623\ \(0\)\
\-\ did\\:\\ 0\\.002704135531106857\ \(0\)\
\-\ identified\\:\\ 0\\.002676132376149274\ \(0\)\
\-\ palpable\\:\\ 0\\.0026543567419805352\ \(0\)\
\-\ signs\\:\\ 0\\.002635737014886989\ \(0\)\
\-\ involving\\:\\ 0\\.0026278766555681804\ \(0\)\
\-\ because\\:\\ 0\\.0026200861670342226\ \(0\)\
\-\ being\\:\\ 0\\.002609805413497422\ \(0\)\
\-\ was\\:\\ 0\\.002598450978651236\ \(0\)\
\-\ inflammatory\\:\\ 0\\.0025971217740508533\ \(0\)\
\-\ side\\:\\ 0\\.00259460692529717\ \(0\)\
\-\ does\\:\\ 0\\.0025553208329395323\ \(0\)\
\-\ neoplasm\\:\\ 0\\.002550531617801865\ \(0\)\
\-\ less\\:\\ 0\\.0025363190221934116\ \(0\)\
\-\ this\\:\\ 0\\.0025270917089766864\ \(0\)\
\-\ 10\\:\\ 0\\.0025246487540288433\ \(0\)\
\-\ type\\:\\ 0\\.0025246487540288433\ \(0\)\
\-\ areas\\:\\ 0\\.0025200238135373067\ \(0\)\
\-\ recent\\:\\ 0\\.0025177204634879904\ \(0\)\
\-\ size\\:\\ 0\\.0025108465130401153\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0024927752709693564\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0024794622424908507\ \(0\)\
\-\ radiation\\:\\ 0\\.002457713628012565\ \(0\)\
\-\ disease\\:\\ 0\\.0024482691344709976\ \(0\)\
\-\ several\\:\\ 0\\.002407618611500778\ \(0\)\
\-\ revealed\\:\\ 0\\.0024035704556232195\ \(0\)\
\-\ mr\\:\\ 0\\.0023796664960091447\ \(0\)\
\-\ right\\:\\ 0\\.0023706355191334357\ \(0\)\
\-\ any\\:\\ 0\\.002358312912420941\ \(0\)\
\-\ normal\\:\\ 0\\.0023481375190168292\ \(0\)\
\-\ examination\\:\\ 0\\.002328153405323896\ \(0\)\
\-\ her\\:\\ 0\\.0022518945297852195\ \(0\)\
\-\ 6\\:\\ 0\\.0022367398434486193\ \(0\)\
\-\ negative\\:\\ 0\\.0022367398434486193\ \(0\)\
\-\ evaluation\\:\\ 0\\.002175494124300445\ \(0\)\
\-\ wall\\:\\ 0\\.002169289325362617\ \(0\)\
\-\ changes\\:\\ 0\\.0021464048871472925\ \(0\)\
\-\ when\\:\\ 0\\.002144900295894834\ \(0\)\
\-\ appearance\\:\\ 0\\.002141898840258231\ \(0\)\
\-\ following\\:\\ 0\\.002125572091937904\ \(0\)\
\-\ however\\:\\ 0\\.0020853357191911222\ \(0\)\
\-\ an\\:\\ 0\\.002071279341428098\ \(0\)\
\-\ presented\\:\\ 0\\.0020415053768820415\ \(0\)\
\-\ if\\:\\ 0\\.002032202834163572\ \(0\)\
\-\ one\\:\\ 0\\.002029563000272256\ \(0\)\
\-\ mild\\:\\ 0\\.00197217655909828\ \(0\)\
\-\ both\\:\\ 0\\.0019125328577441906\ \(0\)\
\-\ on\\:\\ 0\\.0019033067809783386\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.0018406091477930035\ \(0\)\
\-\ increased\\:\\ 0\\.0018321514301486905\ \(0\)\
\-\ bilateral\\:\\ 0\\.0018175440221861912\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.0018052142874515713\ \(0\)\
\-\ 1\\:\\ 0\\.0017820564136369036\ \(0\)\
\-\ 3\\:\\ 0\\.0017537033538181767\ \(0\)\
\-\ other\\:\\ 0\\.0017262388682755905\ \(0\)\
\-\ can\\:\\ 0\\.001698704953960622\ \(0\)\
\-\ well\\:\\ 0\\.001694198907071561\ \(0\)\
\-\ present\\:\\ 0\\.0016915063575211927\ \(0\)\
\-\ large\\:\\ 0\\.001637635786004452\ \(0\)\
\-\ had\\:\\ 0\\.0016159945830330484\ \(0\)\
\-\ lesion\\:\\ 0\\.0015254647028925983\ \(0\)\
\-\ seen\\:\\ 0\\.0014799540885781686\ \(0\)\
\-\ within\\:\\ 0\\.0014286865980596684\ \(0\)\
\-\ that\\:\\ 0\\.0012935852134608444\ \(0\)\
\-\ with\\:\\ 0\\.0012305434821022585\ \(0\)\
\-\ ct\\:\\ 0\\.0010475930354005634\ \(0\)\
\-\ \\.\\:\\ 0\\.0009333795643474042\ \(0\)\
\-\ pain\\:\\ 0\\.0009146434421829401\ \(0\)\
\-\ left\\:\\ 0\\.0008379537855152628\ \(0\)\
\-\ year\\:\\ 0\\.0008379537855152628\ \(0\)\
\-\ patient\\:\\ 0\\.0007507378886208484\ \(0\)\
\-\ a\\:\\ 0\\.0006951793195768646\ \(0\)\
